Federal award
QUIDELORTHO SALES COMPANY, LLC
W81K0024P0021
Contract
Obligated and Ceiling
- Obligated (net)
- $580,438.30
- Ceiling (potential value, not spending)
- $1,053,548.98
- Current value
- $580,438.30
- Gross positive obligations
- $580,438.30
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0024P0021
- Award type code
- B
- Actions
- 6 · Jan 16, 2024 to Apr 3, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 3, 2026 | FY2026 | P00005 | C | $3,472.80 | — |
| Sep 26, 2025 | FY2025 | P00003 | J | $260,016.82 | — |
| Mar 6, 2025 | FY2025 | P00002 | G | $0.00 | — |
| Nov 20, 2024 | FY2025 | P00001 | C | $83,866.14 | — |
| Jan 16, 2024 | FY2024 | P00004 | G | $233,082.54 | — |
| Jan 16, 2024 | FY2024 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.